111 related articles for article (PubMed ID: 21884243)
1. No more pilots, a phase III trial of fibrates in primary biliary cirrhosis is long overdue!
Halliday JS; Chapman RW
J Gastroenterol Hepatol; 2011 Sep; 26(9):1345-6. PubMed ID: 21884243
[No Abstract] [Full Text] [Related]
2. Fibrates as adjuvant therapy for chronic cholestatic liver disease: its time has come.
Ghonem NS; Boyer JL
Hepatology; 2013 May; 57(5):1691-3. PubMed ID: 23174993
[No Abstract] [Full Text] [Related]
3. Comment on biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.
Walker LJ; Newton J; Jones DE; Bassendine MF
Hepatology; 2009 Jan; 49(1):337-8; author reply 338. PubMed ID: 19035342
[No Abstract] [Full Text] [Related]
4. Bezafibrate for primary biliary cirrhosis.
Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2012 Jan; 1():CD009145. PubMed ID: 22259000
[TBL] [Abstract][Full Text] [Related]
5. New weapon for primary biliary cirrhosis from Japan.
Zeniya M
J Gastroenterol; 2003; 38(6):619-20. PubMed ID: 12858848
[No Abstract] [Full Text] [Related]
6. A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.
Corpechot C; Chazouillères O; Rousseau A; Le Gruyer A; Habersetzer F; Mathurin P; Goria O; Potier P; Minello A; Silvain C; Abergel A; Debette-Gratien M; Larrey D; Roux O; Bronowicki JP; Boursier J; de Ledinghen V; Heurgue-Berlot A; Nguyen-Khac E; Zoulim F; Ollivier-Hourmand I; Zarski JP; Nkontchou G; Lemoinne S; Humbert L; Rainteau D; Lefèvre G; de Chaisemartin L; Chollet-Martin S; Gaouar F; Admane FH; Simon T; Poupon R
N Engl J Med; 2018 Jun; 378(23):2171-2181. PubMed ID: 29874528
[TBL] [Abstract][Full Text] [Related]
7. Effect of bezafibrate in primary biliary cirrhosis: a pilot study.
Ohmoto K; Mitsui Y; Yamamoto S
Liver; 2001 Jun; 21(3):223-4. PubMed ID: 11422787
[No Abstract] [Full Text] [Related]
8. Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid.
Lens S; Leoz M; Nazal L; Bruguera M; Parés A
Liver Int; 2014 Feb; 34(2):197-203. PubMed ID: 23998489
[TBL] [Abstract][Full Text] [Related]
9. [Management of PBC cases failing to respond to UDCA].
Tanaka A
Nihon Shokakibyo Gakkai Zasshi; 2013 Jan; 110(1):16-21. PubMed ID: 23303227
[No Abstract] [Full Text] [Related]
10. [Ursodeoxycholic acid combined with bezafibrate in the treatment of refractory primary biliary cholangitis: a meta-analysis].
Feng BL; Yu HH; Shen W
Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):304-311. PubMed ID: 31082343
[No Abstract] [Full Text] [Related]
11. Bezafibrate treatment of primary biliary cirrhosis following incomplete response to ursodeoxycholic acid.
Hazzan R; Tur-Kaspa R
J Clin Gastroenterol; 2010; 44(5):371-3. PubMed ID: 19881358
[TBL] [Abstract][Full Text] [Related]
12. Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid.
Takeuchi Y; Ikeda F; Fujioka S; Takaki T; Osawa T; Yasunaka T; Miyake Y; Takaki A; Iwasaki Y; Kobashi H; Yamamoto K; Itoshima T
J Gastroenterol Hepatol; 2011 Sep; 26(9):1395-401. PubMed ID: 21443659
[TBL] [Abstract][Full Text] [Related]
13. Fibrates for the treatment of pruritus in primary biliary cholangitis: a systematic review and meta-analysis.
Shen N; Pan J; Miao H; Zhang H; Xing L; Yu X
Ann Palliat Med; 2021 Jul; 10(7):7697-7705. PubMed ID: 34353058
[TBL] [Abstract][Full Text] [Related]
14. Combination Therapy of Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis: The End of the Steroid Era in Autoimmune Liver Diseases?
Licinio R; Facciorusso A; Castellaneta NM; Di Leo A
Am J Gastroenterol; 2015 Jul; 110(7):1086. PubMed ID: 26148263
[No Abstract] [Full Text] [Related]
15. Bezafibrate treatment: a new medical approach for PBC patients?
Kanda T; Yokosuka O; Imazeki F; Saisho H
J Gastroenterol; 2003; 38(6):573-8. PubMed ID: 12825134
[TBL] [Abstract][Full Text] [Related]
16. Bezafibrate in the treatment of primary biliary cirrhosis: comparison with ursodeoxycholic acid.
Kurihara T; Niimi A; Maeda A; Shigemoto M; Yamashita K
Am J Gastroenterol; 2000 Oct; 95(10):2990-2. PubMed ID: 11051391
[No Abstract] [Full Text] [Related]
17. Novel Therapies on Primary Biliary Cirrhosis.
Czul F; Levy C
Clin Liver Dis; 2016 Feb; 20(1):113-30. PubMed ID: 26593294
[TBL] [Abstract][Full Text] [Related]
18. Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis-are we there yet?
Rodrigues PM; Banales JM
Aliment Pharmacol Ther; 2022 Jan; 55(2):247-248. PubMed ID: 34970762
[No Abstract] [Full Text] [Related]
19. A novel treatment for refractory primary biliary cirrhosis?
Miyaguchi S; Ebinuma H; Imaeda H; Nitta Y; Watanabe T; Saito H; Ishii H
Hepatogastroenterology; 2000; 47(36):1518-21. PubMed ID: 11148991
[TBL] [Abstract][Full Text] [Related]
20. Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis-are we there yet? Authors' reply.
Sorda JA; González Ballerga E; Barreyro FJ; Daruich J
Aliment Pharmacol Ther; 2022 Jan; 55(2):249-250. PubMed ID: 34970761
[No Abstract] [Full Text] [Related]
[Next] [New Search]